Related Experiment Video
Updated: Apr 5, 2026
09:10
The Lower Body Positive Pressure Treadmill for Knee Osteoarthritis Rehabilitation
Published on: July 22, 2019
11.4K
Treadmill training for patients with Parkinson's disease
Jan Mehrholz1, Joachim Kugler, Alexander Storch
1Wissenschaftliches Institut, Private Europäische Medizinische Akademie der Klinik Bavaria in Kreischa GmbH, An der Wolfsschlucht 1-2, Kreischa, Germany, 01731.
The Cochrane Database of Systematic Reviews
|August 23, 2015
Summary
Treadmill training improves gait speed and stride length in Parkinson's disease (PD) patients. While beneficial, the gains are small to moderate, and long-term effects remain unknown.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Movement Disorders
Background:
- Treadmill training is a common rehabilitation technique.
- It is suggested to enhance gait parameters in Parkinson's disease (PD) patients.
Purpose of the Study:
- To evaluate the efficacy of treadmill training for improving gait in PD patients.
- To assess the safety and acceptability of this therapeutic approach.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs).
- Searched multiple databases including Cochrane, MEDLINE, and EMBASE up to September 2014.
- Included 18 RCTs comparing treadmill training with no treadmill training.
Main Results:
- Treadmill training significantly improved gait speed (0.09 m/s) and stride length (0.05 m).
- Improvements in walking distance and cadence were not statistically significant.
- No increased risk of dropout or adverse events was observed.
Conclusions:
- Treadmill training offers moderate to low-quality evidence for improving key gait parameters in PD patients.
- The clinical benefits are potentially small to moderate, with uncertainties regarding long-term effects and heterogeneity across studies.
- This therapy appears more beneficial than physiotherapy alone for gait hypokinesia without increased risk.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:15Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K